ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/(2S)-1-((2S)-2-(((1R)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)propanoyl)pyrrolidine-2-carboxylic acid
C20H28N2O5
376.4 g/mol
API

N-((1R)-1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl-L-proline

CAS76420-74-1
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

This compound is a peptide and an active pharmaceutical ingredient. It is used as a pharmaceutical raw material in manufacturing and research.

pharmaceutical manufacturingresearch compound

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.81

Enalaprilat

CAS76420-72-9

pharmaceutical raw material

ReferenceSame Category

Sultamicillin

CAS76497-13-7

pharmaceutical raw material

ReferenceSame Category

Lexidronam pentasodium

CAS7651-99-2

pharmaceutical raw material

ReferenceSame Category

Alclometasone 17-propionate

CAS76576-24-4

pharmaceutical raw material

ReferenceSame Category

Valproate semisodium

CAS76584-70-8

pharmaceutical raw material

Referencestereoisomer of

Enalapril maleate

CAS76095-16-4

pharmaceutical raw material

Referencesame scaffold

N-nitroso-enalapril

CAS2994317-06-3

pharmaceutical intermediate

Referencesame scaffold

Enalaprilat D5

CAS349554-00-3

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-1-[(2S)-2-[[(2R)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid

InChIKey

GBXSMTUPTTWBMN-UAGQMJEPSA-N

SMILES

CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O

Synonyms (12)
  • Enalapril EP Impurity A
  • Enalapril Maleate EP Impurity A ((S,S,R)-Enalapril)
  • (S, S, R)-Enalapril
  • Enalapril impurity A
  • Enalapril maleate impurity A

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→